Last reviewed · How we verify
Bon one in Arm 3
Bon one in Arm 3 is a medication that works by [insert mechanism here, if known]
Bon one in Arm 3 is a medication that works by [insert mechanism here, if known] Used for Atrial fibrillation for stroke prevention.
At a glance
| Generic name | Bon one in Arm 3 |
|---|---|
| Sponsor | MinaPharm Pharmaceuticals |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Unfortunately, I do not have enough information to provide a deeper explanation of the mechanism.
Approved indications
- Atrial fibrillation for stroke prevention
Common side effects
- Unknown
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bon one in Arm 3 CI brief — competitive landscape report
- Bon one in Arm 3 updates RSS · CI watch RSS
- MinaPharm Pharmaceuticals portfolio CI